LAVAL, QC, Sept. 13 /CNW/ - Labopharm Inc. (TSX: DDS, NASDAQ:DDSS) today
announced the appointment of Mark D'Souza to the position of Chief Financial
Officer. Labopharm today also announced that Warren Whitehead is leaving the
Company to pursue other opportunities.
